← Back to Intel
Insider ActivityPRLD
Bonita David P, Director, 10% Owner at Prelude Therapeutics Inc, bought $5.0M of PRLD
Updated Jun 14, 2026
Bonita David P
Director, 10% Owner
Prelude Therapeutics Inc ·
$PRLD
Transaction Details
| Insider | Bonita David P |
|---|---|
| Title | Director, 10% Owner |
| Company | Prelude Therapeutics Inc |
| Ticker | PRLD |
| Transaction Type | Purchase |
| Transaction Date | 2026-04-21 |
| Shares Traded | 1,126,126 |
| Price Per Share | $4.44 |
| Total Value | $5.0M |
| Filed Date | 2026-04-23 |
| Accession Number | 0000947871-26-000462 |
Ownership Context
| Shares Owned After Transaction | 1,126,126 |
|---|---|
| Ownership Type | Indirect |
SEC Filing
Accession: 0000947871-26-000462
Other Insider Trades — PRLD
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Sandor Victor | Insider | traded | — | 2026-06-09 |
| BAKER BROS. ADVISORS LP | Insider | traded | — | 2026-06-09 |
| FRIEDMAN PAUL A | Insider | traded | — | 2026-06-09 |
| Bonita David P | Insider | traded | — | 2026-06-09 |
| Dorton Katina | Insider | traded | — | 2026-06-09 |
| Babler Martin | Insider | traded | — | 2026-06-09 |
| Morris Charles Q | Chief Medical Officer | traded | $2.1M | 2026-05-01 |
| RA CAPITAL MANAGEMENT, L.P. | Insider | traded | — | 2026-04-27 |
| BAKER BROS. ADVISORS LP | Insider | bought | $509K | 2026-04-21 |
| Bonita David P | Director, 10% Owner | bought | $7.5M | 2026-04-21 |
Other Trades by Bonita David P
| Ticker | Company | Action | Value | Date |
|---|---|---|---|---|
| PRLD | Prelude Therapeutics Inc | traded | — | 2026-06-09 |
| PRLD | Prelude Therapeutics Inc | bought | $7.5M | 2026-04-21 |
| IMA | ImageneBio, Inc. | bought | — | 2026-04-14 |
| IMA | ImageneBio, Inc. | bought | — | 2026-04-14 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for PRLD — Prelude Therapeutics Inc →
Track PRLD insider activity in real time on The Wire →
Get alerts when Bonita David P files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 14, 2026 at 07:16 UTC